Switch to:
More From Other Websites
Dissecting Roche’s Performance across Its Segments Jul 22 2016
Reasons behind Roche’s Better-than-Expected 2Q16 Performance Jul 22 2016
Amgen, Allergan biosimilar found as effective as Roche cancer drug Jul 21 2016
[$$] Roche says UK faces losing lead in medical research after Brexit Jul 21 2016
Roche CEO Confident Business Will Succeed Despite Turmoil Jul 21 2016
Roche CEO Confident Business Will Succeed Despite Turmoil Jul 21 2016
[$$] Roche Sales Rise on Cancer Drugs Jul 21 2016
Roche Beats First-Half Forecasts as Cancer Drug Sales Rise Jul 21 2016
Pairing New Cancer Drugs With Older Ones Bolsters Roche Profit Jul 21 2016
What Are Roche’s Truest Growth Opportunities? Jul 19 2016
Inside Roche’s Strategy to Offset Revenue Declines Jul 19 2016
Roche's Gazyva Fails in Phase III B-cell Lymphoma Study Jul 18 2016
Gauging Growth Expectations for Roche in 2Q16 and 2016 Jul 18 2016
Roche Blood Cancer Medicine Fails to Show Major Improvement Jul 18 2016
Genentech Provides Update on Phase III Study of Gazyva® in People With Previously Untreated Diffuse... Jul 18 2016
How Much Upward Potential Does Roche Really Have? Jul 15 2016
CoaguChek® PT/ INR devices for use at the point of care and for patient self-testing remain a safe... Jul 15 2016
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan Jul 14 2016
Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK